ArticleBMC genomics2026
Proteomic analysis reveals the molecular mechanisms of deoxynivalenol-induced injury in the jejunum of piglets.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Deoxynivalenol (DON), a prevalent Fusarium mycotoxin, poses a significant threat to intestinal health in piglets. This study established a deoxynivalenol (DON) intoxication model in piglets, revealing compromised intestinal barrier function accompanied by inflammatory responses and oxidative stress. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS) on intestinal samples from piglets (n = 6 per group), we identified 8,084 proteins, of which 124 showed significantly altered expression following DON exposure. Bioinformatic analysis indicated that the differentially expressed proteins (DEPs) were significantly enriched in pathways such as glutathione metabolism and cytochrome P450-mediated drug metabolism, suggesting the activation of oxidative defense systems and xenobiotic detoxification mechanisms. Protein-protein interaction (PPI) network analysis uncovered potential disruptions in protein synthesis and secretion processes induced by DON. Notably, the solute carrier transporter SLC16A10 exhibited the most pronounced upregulation, implying that DON may exacerbate intestinal injury by disrupting amino acid transport and metabolic homeostasis. This study systematically delineates the protein expression profile associated with DON-induced intestinal damage, providing new targets for understanding its toxicological mechanisms and developing intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.